Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
<p><strong>Background</strong><br> The CC genotype of the <i>IFNL4</i> gene is known to be associated with increased Hepatitis C (HCV) cure rates with interferon-based therapy and may contribute to cure with direct acting antivirals. The Genedrive® <i>IFNL4&...
Principais autores: | Sy, A, McCabe, L, Hudson, E, Ansari, AM, Pedergnana, V, Lin, S-K, Santana, S, Fiorino, M, Ala, A, Stone, B, Smith, M, Nelson, M, Barclay, ST, McPherson, S, Ryder, SD, Collier, J, Barnes, E, Walker, AS, Pett, SL, Cooke, G |
---|---|
Outros Autores: | STOP-HCV-1 trial team |
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Public Library of Science
2023
|
Registros relacionados
-
Impact of IFNL4 genotype on interferon-stimulated gene expression during daa therapy for Hepatitis C
por: Ramamurthy, N, et al.
Publicado em: (2018) -
Impact of IFNL4 genetic variants on sustained virologic response and viremia in hepatitis C virus genotype 3 patients
por: Pedergnana, V, et al.
Publicado em: (2019) -
Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus
por: Simmonds, P, et al.
Publicado em: (2020) -
The design and statistical aspects of VIETNARMS: A strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
por: McCabe, L, et al.
Publicado em: (2020) -
Testing for respiratory viruses in children: to swab or not to swab
por: Gill, PJ, et al.
Publicado em: (2018)